Teva Pharmaceutical Industries Ltd. announced the publication of data from the Phase III HALO study evaluating the efficacy, safety, and...
UCB announced positive topline results from C-AXSPAND, a Phase 3 placebo controlled study to investigate the efficacy of CIMZIA® (certolizumab...
Zymeworks Inc. , a clinical-stage biopharmaceutical company developing multifunctional therapeutics, and Daiichi Sankyo Company, Limited announced that they entered into...
Eli Lilly and Company announced that new results from a number of studies across the company's oncology product and pipeline...
Takeda Pharmaceutical Company Limited announced that the company will feature a total of 14 Takeda Oncology-sponsored presentations at two upcoming...
Celgene Corporation announced that data from more than 60 company-sponsored, cooperative group and investigator-initiated clinical studies evaluating Celgene agents will...
Eli Lilly and Company announced that galcanezumab met its primary endpoint in a Phase 3 study of patients with episodic...
AbbVie , a research-based global biopharmaceutical company, announced it will present data about the company's portfolio of investigational oncology medicines...
Teva Pharmaceutical Industries Ltd. announced the publication of data from the Phase III HALO study evaluating the efficacy, safety, and...
CPhI & P-MEC China – organized by UBM and UBM SINEXPO – takes place at the Shanghai New International Expo...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
